<p class="title">Scientists have developed a synthetic gene network that serves as an early warning system against cancer, producing visible moles on the skin as soon as the system detects the development of a tumour in the body.</p>.<p class="bodytext">Cancer has become one of the top causes of death in industrialised countries. Many of those affected are diagnosed only after a tumour has developed extensively. This often reduces the chance of recovery significantly.</p>.<p class="bodytext">The ability to detect such tumours reliably and early would not only save lives, but also reduce the need for expensive, stressful treatment.</p>.<p class="bodytext">The gene network, developed by researchers from ETH Zurich in Switzerland, recognises the four most common types of cancer - prostate, lung, colon and breast cancer - at a very early stage when the level of calcium in the blood is elevated due to a developing tumour.</p>.<p class="bodytext">The early warning system comprises a genetic network that researchers integrate into human body cells, which in turn are inserted into an implant.</p>.<p class="bodytext">This encapsulated gene network is then implanted under the skin where it constantly monitors the blood calcium level.</p>.<p class="bodytext">As soon as the calcium level exceeds a particular threshold value over a longer period of time, a signal cascade is triggered that initiates production of the body's tanning pigment melanin in the genetically modified cells. The skin then forms a brown mole that is visible to the naked eye.</p>.<p class="bodytext">The mole appears long before cancer becomes detectable through conventional diagnosis.</p>.<p class="bodytext">"An implant carrier should then see a doctor for a further evaluation after the mole appears," said Martin Fussenegger, a professor at ETH Zurich.</p>.<p class="bodytext">The mole does not mean that the person is likely to die soon, he said. It simply means that clarification and if necessary treatment is needed.</p>.<p class="bodytext">The researchers used calcium as the indicator of the development of the four types of cancer, as it is regulated strongly in the body. Bones serve as a buffer that can balance out concentration differences.</p>.<p class="bodytext">However, when too much calcium is detected in the blood, this may serve as a sign for one of the four cancers.</p>.<p class="bodytext">Early detection increases the chance of survival significantly. For example, if breast cancer is detected early, the chance of recovery is 98 percent.</p>.<p class="bodytext">However, if a tumour is diagnosed too late, only one in four women has a good chance of recovery.</p>.<p class="bodytext">"Nowadays, people generally go to the doctor only when a tumour begins to cause problems. Unfortunately, by that point it is often too late," Fussenegger said.</p>.<p class="bodytext">The implant is intended primarily for self-monitoring, making it very cost effective, he said.</p>.<p class="bodytext">The disadvantage is that the service life of such an implant is limited.</p>.<p class="bodytext">"Encapsulated living cells last for about a year, according to other studies. After that, they must be inactivated and replaced," Fussenegger said.</p>.<p class="bodytext">The researchers have tested their early warning system in a mouse model and on pig skin. It functioned reliably during these tests. Moles developed only when the calcium concentration reached a high level. </p>
<p class="title">Scientists have developed a synthetic gene network that serves as an early warning system against cancer, producing visible moles on the skin as soon as the system detects the development of a tumour in the body.</p>.<p class="bodytext">Cancer has become one of the top causes of death in industrialised countries. Many of those affected are diagnosed only after a tumour has developed extensively. This often reduces the chance of recovery significantly.</p>.<p class="bodytext">The ability to detect such tumours reliably and early would not only save lives, but also reduce the need for expensive, stressful treatment.</p>.<p class="bodytext">The gene network, developed by researchers from ETH Zurich in Switzerland, recognises the four most common types of cancer - prostate, lung, colon and breast cancer - at a very early stage when the level of calcium in the blood is elevated due to a developing tumour.</p>.<p class="bodytext">The early warning system comprises a genetic network that researchers integrate into human body cells, which in turn are inserted into an implant.</p>.<p class="bodytext">This encapsulated gene network is then implanted under the skin where it constantly monitors the blood calcium level.</p>.<p class="bodytext">As soon as the calcium level exceeds a particular threshold value over a longer period of time, a signal cascade is triggered that initiates production of the body's tanning pigment melanin in the genetically modified cells. The skin then forms a brown mole that is visible to the naked eye.</p>.<p class="bodytext">The mole appears long before cancer becomes detectable through conventional diagnosis.</p>.<p class="bodytext">"An implant carrier should then see a doctor for a further evaluation after the mole appears," said Martin Fussenegger, a professor at ETH Zurich.</p>.<p class="bodytext">The mole does not mean that the person is likely to die soon, he said. It simply means that clarification and if necessary treatment is needed.</p>.<p class="bodytext">The researchers used calcium as the indicator of the development of the four types of cancer, as it is regulated strongly in the body. Bones serve as a buffer that can balance out concentration differences.</p>.<p class="bodytext">However, when too much calcium is detected in the blood, this may serve as a sign for one of the four cancers.</p>.<p class="bodytext">Early detection increases the chance of survival significantly. For example, if breast cancer is detected early, the chance of recovery is 98 percent.</p>.<p class="bodytext">However, if a tumour is diagnosed too late, only one in four women has a good chance of recovery.</p>.<p class="bodytext">"Nowadays, people generally go to the doctor only when a tumour begins to cause problems. Unfortunately, by that point it is often too late," Fussenegger said.</p>.<p class="bodytext">The implant is intended primarily for self-monitoring, making it very cost effective, he said.</p>.<p class="bodytext">The disadvantage is that the service life of such an implant is limited.</p>.<p class="bodytext">"Encapsulated living cells last for about a year, according to other studies. After that, they must be inactivated and replaced," Fussenegger said.</p>.<p class="bodytext">The researchers have tested their early warning system in a mouse model and on pig skin. It functioned reliably during these tests. Moles developed only when the calcium concentration reached a high level. </p>